Vaxart Submits Proxy Statement for Reverse Stock Split to Support Resumption of Trading on Nasdaq

Stock Information for Athenex Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Athenex Inc.

Vaxart to Host Virtual Stockholder Fireside Chat on Wednesday, August 20 to Discuss Reverse Stock Split Proposal
Vaxart Provides Business Update and Reports Second Quarter 2025 Financial Results
Vaxart CEO Issues Letter to Stockholders
Vaxart to Host Second Quarter 2025 Business Update and Financial Results Conference Call on August 13
Vaxart Announces Trading on OTCQX Best Market
OTC Markets Group Welcomes Vaxart, Inc. to OTCQX
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.